BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 17446326)

  • 1. Subtyping method for Escherichia coli shiga toxin (verocytotoxin) 2 variants and correlations to clinical manifestations.
    Persson S; Olsen KE; Ethelberg S; Scheutz F
    J Clin Microbiol; 2007 Jun; 45(6):2020-4. PubMed ID: 17446326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms.
    Friedrich AW; Bielaszewska M; Zhang WL; Pulz M; Kuczius T; Ammon A; Karch H
    J Infect Dis; 2002 Jan; 185(1):74-84. PubMed ID: 11756984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shiga toxin-producing Escherichia coli in Montana: bacterial genotypes and clinical profiles.
    Jelacic JK; Damrow T; Chen GS; Jelacic S; Bielaszewska M; Ciol M; Carvalho HM; Melton-Celsa AR; O'Brien AD; Tarr PI
    J Infect Dis; 2003 Sep; 188(5):719-29. PubMed ID: 12934188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virulence factors for hemolytic uremic syndrome, Denmark.
    Ethelberg S; Olsen KE; Scheutz F; Jensen C; Schiellerup P; Enberg J; Petersen AM; Olesen B; Gerner-Smidt P; Mølbak K
    Emerg Infect Dis; 2004 May; 10(5):842-7. PubMed ID: 15200817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subtyping of Shiga toxin 2 variants in human-derived Shiga toxin-producing Escherichia coli strains isolated in Japan.
    Nakao H; Kimura K; Murakami H; Maruyama T; Takeda T
    FEMS Immunol Med Microbiol; 2002 Dec; 34(4):289-97. PubMed ID: 12443829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of O157 versus non-O157 Shiga toxin-producing Escherichia coli infections in Minnesota, 2000-2006.
    Hedican EB; Medus C; Besser JM; Juni BA; Koziol B; Taylor C; Smith KE
    Clin Infect Dis; 2009 Aug; 49(3):358-64. PubMed ID: 19548834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New aspects in the pathogenesis of enteropathic hemolytic uremic syndrome.
    Karch H; Friedrich AW; Gerber A; Zimmerhackl LB; Schmidt MA; Bielaszewska M
    Semin Thromb Hemost; 2006 Mar; 32(2):105-12. PubMed ID: 16575685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O148 Shiga toxin-producing Escherichia coli outbreak: microbiological investigation as a useful complement to epidemiological investigation.
    Espié E; Grimont F; Vaillant V; Montet MP; Carle I; Bavai C; de Valk H; Vernozy-Rozand C
    Clin Microbiol Infect; 2006 Oct; 12(10):992-8. PubMed ID: 16961636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic typing of shiga toxin 2 variants of Escherichia coli by PCR-restriction fragment length polymorphism analysis.
    De Baets L; Van der Taelen I; De Filette M; Piérard D; Allison L; De Greve H; Hernalsteens JP; Imberechts H
    Appl Environ Microbiol; 2004 Oct; 70(10):6309-14. PubMed ID: 15466582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Isolation of Shiga-toxin-producing Escherichia coli strains during a gastrointestinal outbreak at a day care center in Mar del Plata City].
    Gomez D; Miliwebsky E; Silva A; Deza N; Zotta C; Cotella O; Martínez Espinosa E; Chinen I; Fernández Pascua C; Rivas M
    Rev Argent Microbiol; 2005; 37(4):176-83. PubMed ID: 16502636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shiga toxin-negative attaching and effacing Escherichia coli: distinct clinical associations with bacterial phylogeny and virulence traits and inferred in-host pathogen evolution.
    Bielaszewska M; Middendorf B; Köck R; Friedrich AW; Fruth A; Karch H; Schmidt MA; Mellmann A
    Clin Infect Dis; 2008 Jul; 47(2):208-17. PubMed ID: 18564929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiplex PCR for direct detection of Shiga toxigenic Escherichia coli strains producing the novel subtilase cytotoxin.
    Paton AW; Paton JC
    J Clin Microbiol; 2005 Jun; 43(6):2944-7. PubMed ID: 15956427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shiga toxin activatable by intestinal mucus in Escherichia coli isolated from humans: predictor for a severe clinical outcome.
    Bielaszewska M; Friedrich AW; Aldick T; Schürk-Bulgrin R; Karch H
    Clin Infect Dis; 2006 Nov; 43(9):1160-7. PubMed ID: 17029135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome.
    Orth D; Grif K; Khan AB; Naim A; Dierich MP; Würzner R
    Diagn Microbiol Infect Dis; 2007 Nov; 59(3):235-42. PubMed ID: 17931818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inducible stx2 phages are lysogenized in the enteroaggregative and other phenotypic Escherichia coli O86:HNM isolated from patients.
    Iyoda S; Tamura K; Itoh K; Izumiya H; Ueno N; Nagata K; Togo M; Terajima J; Watanabe H
    FEMS Microbiol Lett; 2000 Oct; 191(1):7-10. PubMed ID: 11004392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections.
    Serna A; Boedeker EC
    Curr Opin Gastroenterol; 2008 Jan; 24(1):38-47. PubMed ID: 18043231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal hemolytic uremic syndrome after mother-to-child transmission of a low-pathogenic stx2b harboring shiga toxin-producing Escherichia coli.
    Stritt A; Tschumi S; Kottanattu L; Bucher BS; Steinmann M; von Steiger N; Stephan R; Hächler H; Simonetti GD
    Clin Infect Dis; 2013 Jan; 56(1):114-6. PubMed ID: 23042969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open-source genomic analysis of Shiga-toxin-producing E. coli O104:H4.
    Rohde H; Qin J; Cui Y; Li D; Loman NJ; Hentschke M; Chen W; Pu F; Peng Y; Li J; Xi F; Li S; Li Y; Zhang Z; Yang X; Zhao M; Wang P; Guan Y; Cen Z; Zhao X; Christner M; Kobbe R; Loos S; Oh J; Yang L; Danchin A; Gao GF; Song Y; Li Y; Yang H; Wang J; Xu J; Pallen MJ; Wang J; Aepfelbacher M; Yang R;
    N Engl J Med; 2011 Aug; 365(8):718-24. PubMed ID: 21793736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of shiga toxin type 2 variant B-subunit in Escherichia coli strains from asymptomatic human carriers by PCR-RFLP.
    Stephan R; Hoelzle LE
    Lett Appl Microbiol; 2000 Aug; 31(2):139-42. PubMed ID: 10972716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postdiarrheal Shiga toxin-mediated hemolytic uremic syndrome similar to septic shock.
    Valles PG; Pesle S; Piovano L; Davila E; Peralta M; Principi I; Lo Giudice P
    Medicina (B Aires); 2005; 65(5):395-401. PubMed ID: 16296634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.